Predictors of multidrug-and extensively drug-resistant tuberculosis in a high HIV prevalence community

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Andrews, Jason R ^a   Shah, N Sarita ^b   Weissman, Darren ^b   Moll, Anthony P ^c   Friedland, Gerald ^d   Gandhi, Neel R ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Philanjalo and Church of Scotland Hospital   (South Africa)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; POPULATION BASED CASE CONTROL STUDY; PREDICTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOUTH AFRICA; CASE CONTROL STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; PREVALENCE; RISK;

ADULT; CASE-CONTROL STUDIES; COMMUNICABLE DISEASE CONTROL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; ODDS RATIO; PREVALENCE; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 78650806538     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015735     Document Type: Article

References (39)

1. Seung KJ, Omatayo DB, Keshavjee S, Furin JJ, Farmer PE, et al. (2009) Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLoS ONE 4: e7186.
2. Calver AD, Falmer AA, Murray M, Strauss OJ, Streicher EM, et al. (2010) Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerging Infect Dis 16: 264-271.
3. Hassim S, Shaw PA, Sangweni P, Malan L, Ntshani E, et al. (2010) Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples. Clin Infect Dis 50: 1053-1059.
4. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, et al. (2010) HIV coinfection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 181: 80-86.
5. Dheda K, Shean K, Zumla A, Badri M, Streicher EM, et al. (2010) Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet 375: 1798-1807.
6. World Health Organization (2009) Global Tuberculosis Control: A short update to the 2009 report. Geneva, Switzerland.
7. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, et al. (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368: 1575-1580.
8. Basu S, Friedland GH, Medlock J, Andrews JR, Shah NS, et al. (2009) Averting epidemics of extensively drug-resistant tuberculosis. Proc Natl Acad Sci USA 106: 7672-7677.
9. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, et al. (2008) Comprehensive treatment of extensively drug-resistant tuberculosis.NEngl J Med 359: 563-574.
10. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, et al. (2003) Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 348: 119-128.
11. Solari L, Acuna-Villaorduna C, Soto A, Agapito J, Perez F, et al. (2008) A clinical prediction rule for pulmonary tuberculosis in emergency departments. Int J Tuberc Lung Dis 12: 619-624.
12. Novelli EM, Hittner JB, Davenport GC, Ouma C, Were T, et al. (2010) Clinical predictors of severe malarial anaemia in a holoendemic Plasmodium falciparum transmission area. Br J Haematol 149: 711-721.
13. Costello C, Nelson KE, Jamieson DJ, Spacek L, Sennun S, et al. (2005) Predictors of low CD4 count in resource-limited settings: based on an antiretroviral-naive heterosexual thai population. J Acquir Immune Defic Syndr 39: 242-248.
14. Mwaniki MK, Nokes DJ, Ignas J, Munywoki P, Ngama M, et al. (2009) Emergency triage assessment for hypoxaemia in neonates and young children in a Kenyan hospital: an observational study. Bull World Health Organ 87: 263-270.
15. Vashakidze L, Salakaia A, Shubladze N, Cynamon M, Barbakadze K, et al. (2009) Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in Georgia. Int J Tuberc Lung Dis 13: 1148-1153.
16. Schreiber Y, Herrera A, Wilson D, Wallengren K, Draper R, et al. (2009) Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area. Int J Tuberc Lung Dis 13: 1274-1280.
17. Escombe AR, Moore DAJ, Gilman RH, Pan W, Navincopa M, et al. (2008) The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med 5: e188.
18. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, et al. (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320: 545-550.
19. Brust JCM, Gandhi NR, Carrara H, Osburn G, Padayatchi N (2010) High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003. Int J Tuberc Lung Dis 14: 413-419.
20. Patel KB, Belmonte R, Crowe HM (1995) Drug malabsorption and resistant tuberculosis in HIV-infected patients. N Engl J Med 332: 336-337.
21. South Africa Department of Health (2004) The South African National Tuberculosis Control Programme Practical Guidelines.
22. Vittinghoff E, Glidden D, Shiboski S, McCulloch C (2004) Regression Methods in Biostatistics. New York: Springer.
23. World Health Organization. (2010) Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. Geneva: World Health Organization.
24. Keshavjee S, Gelmanova I, Farmer P, Mishustin S, Strelis A, et al. (2008) Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 372: 1403-9.
25. Andrews JR, Gandhi NR, Moodley P, Shah NS, Bohlken L, et al. (2008) Exogenous reinfection as a cause of multidrug-resistant and extensively drugresistant tuberculosis in rural South Africa. J Infect Dis 198: 1582-1589.
26. Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, et al. (2007) Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 370: 1500-1507.
27. Churchyard GJ, Corbett EL, Kleinschmidt I, Mulder D, De Cock KM (2000) Drug-resistant tuberculosis in South African gold miners: incidence and associated factors. Int J Tuberc Lung Dis 4: 433-440.
28. Punnotok J, Shaffer N, Naiwatanakul T, Pumprueg U, Subhannachart P, et al. (2000) Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand. Int J Tuberc Lung Dis 4: 537-543.
29. Campos PE, Suarez PG, Sanchez J, Zavala D, Arevalo J, et al. (2003) Multidrugresistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerging Infect. Dis 9: 1571-1578.
30. Gordin FM, Nelson ET, Matts JP, Cohn DL, Ernst J, et al. (1996) The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am J Respir Crit Care Med 154: 1478-1483.
31. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, et al. (2001) Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 5: 887-893.
32. Suchindran S, Brouwer ES, Van Rie A (2009) Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS ONE 4: e5561.
33. Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G (2007) Multidrugresistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. J Infect Dis 196(Suppl 3): S482-490.
34. Shenoi SV, Escombe AR, Friedland G (2010) Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts. Clin Infect Dis 50(Suppl 3): S231-237.
35. Kliiman K, Altraja A (2009) Predictors of extensively drug-resistant pulmonary tuberculosis. Ann Intern Med 150: 766-775.
36. Cox HS, McDermid C, Azevedo V, Muller O, Coetzee D, et al. (2010) Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS ONE 5: e13901.
37. Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, et al. (2005) A casecontrol study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist 11: 62-67.
38. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, et al. (2005) Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 293: 2726-2731.
39. Dowdy DW, Chaisson RE, Maartens G, Corbett EL, Dorman SE (2008) Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci USA 105: 11293-11298.